A generation ago, a cancer diagnosis meant the patient had a 50% chance of living beyond five years. Today, cancer is still an awful disease, but thanks to incredible medical advances, survival is far more likely than ever before. That’s not the only good news. In fact, there is hope that as soon as a decade from now, cancer could possibly be a managed disease instead of a killer.
In this episode, pharmaceutical expert and cancer researcher, Sara Kenkare-Mitra, shares her how she got into the pharmaceutical field, the long road to creating an effective drug, and the importance of celebrating failure.
Sara discusses:
Part One: The Road to Making a Drug
Growing up in India, moving from India to the United States, culture shock, building resilience, joining Genentech, becoming a leader, how her leadership skills as a manager needed to evolve to lead a team of 550 people, the importance of technical competence in a large organization, the drug development process.
Part Two: Curing Cancer
Why it’s good to celebrate failure, how pharmaceutical companies are curing cancer, advice for young women entering STEM fields, encouraging your teams to learn from failures, meditation and leadership, overcoming the minority effect, advocating for yourself, how being a mother made her a more effective leader, the future of cancer, the role of empathy in leadership and drug development.
Organizations, People, Resources, Places Mentioned.
Mumbai, India, Genentech, Austin, Texas, University of Texas - Austin, UCSF (University of California, San Francisco), San Francisco, Kadcyla (Her2+ Breast cancer drug), the FDA (U.S. Food & Drug Administration)
To learn more about Sara and Genentech, please visit www.Gene.com.
Read More